Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium bromide plus sustained-release theophylline for moderate stable COPD
ChiCTR-TRC-07000177Phase 4Completed
- Sponsor
- The First Hospital of Lanzhou University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tiotropium and theophylline in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by The First Hospital of Lanzhou University. Primary endpoints: Quality of life, Side effects and 1 more. Started Jan 2008; status: completed.
02
Drugs
tiotropiumtheophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-TRC-07000177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-07000177.